Ontario’s COVID-19 Genomics Rapid Response Coalition
To accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario and to help expedite patient genome sequencing through a coordinated approach bringing together all of the province’s genomics resources and capacity to enable timely and comprehensive genomic analysis.
Standardized Sequencing Methodologies
Data Management & Sharing
The ON-CoV Coalition is designed to provide for method standardization and coordination of:
Collecting Patient Samples and Metadata
Data Curation and Management
This work will expedite real-time testing and reporting to inform public health and public policy, help manage and overcome the ongoing COVID-19 crisis and ensure scalability for Ontario’s future pandemics preparedness.
Genomic technologies are the foundation for the solutions necessary to combat the ongoing COVID-19
pandemic. Ontario’s world-leading expertise in genomics, bioinformatics, genomics epidemiology, and artificial intelligence, can expedite Ontario’s response to COVID-19.
The results reported by the Coalition will inform vaccine and therapeutic development.
Why Ontario Genomics?
Over the past 20 years, Ontario Genomics, together with the Ontario Government, Genome Canada, and academic, clinical and industry partners, has built a world-leading genomics ecosystem in Ontario with over $2.7B in funding leveraged for research, translation and the establishment of genomic technology platforms.
Ontario Genomics is well-positioned to provide and promote:
ONCoV Genomics Coalition Steering Committee
ONCoV Genomics Coalition Members
Hospital for Sick Children / University of Toronto
TCAG / CGEn
University of Toronto
Public Health Ontario
Sinai Health Systems
Ontario Institute for Cancer Research
Health Sciences North
Kingston Health Sciences Centre / Queen’s University
Dalla Lana School of Public Health, University of Toronto
Sunnybrook Health Sciences / University of Toronto
Unity Health Toronto / University of Toronto
Peter Munk Cardiac Centre, UHN / University of Toronto
We are proactively working with the research community, partner genome centres, and governments to accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario. Learn more and stay up-to-date about our COVID-19 programs and important resources.
Public Policy Forum Podcast: Understanding a Disease – COVID-19 and Genomics Canada Podcast
June 1, 2020
COVID-19 is a virus that impacts different individuals in similar ways. In this podcast, Dr. Bettina Hamelin, President & CEO of Ontario Genomics and Dr. Rob Annan, President & CEO of Genome Canada explore the scientific aspects of COVID-19 dynamics and how it affects individuals.
Hospital News: Dr. Samira Mubareka - It’s all in the genome: Preparing for the next waves of COVID-19
May 28, 2020
On January 24th, Sunnybrook Health Sciences admitted the first Canadian patient with COVID-19. The traveller had just returned from Wuhan, China, the epicentre of the virus outbreak. He presented with a respiratory illness due to SARS-CoV-2, the coronavirus that causes COVID-19. At that moment I realized this virus would come to dominate our reality, both at Sunnybrook and across Canada.
COVID-19 Research: Genomics, Rapid Execution & Funding featuring Samira Mubareka
Ontario’s infectious disease expert speaks about her COVID-19 research in an interview with TheFuturEconomy.ca. Leading Sunnybrook’s Coronavirus response, her work on isolating & understanding the virus is helping roll out rapid research efforts.
April 27, 2020